Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Week in Review

Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Week in Review: Under Pressure from US Congress, WuXi AppTec Resigns from BIO

Week in Review: EurekaBio Raises $40 Million to Support Lentiviral Vector Platform

Week in Review: Mabwell Sells Ex-China Rights to Rare Disease Therapy in $412 Million Deal

Week in Review: AlphaGen and ArtBio Form China-US Radioligand Partnership

Week in Review: LianBio to Close Operations; Will Pay $528 Million to Shareholders

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital